MedTrace Logo

Polymyalgia Rheumatica and Giant Cell Arteritis

NCT02985424 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2017-04-25

No results posted yet for this study

Summary

The purpose of this study is to delineate the association of the 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) detected vasculitis pattern of the large vessels (PET positivity) and the clinical picture of Polymyalgia Rheumatica (PMR)/Giant Cell Arteritis (GCA) .

Conditions

  • Polymyalgia Rheumatica
  • Giant Cell Arteritis

Interventions

OTHER

18F-FDG PET/CT

18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER

  • Svendborg Hospital

    lead OTHER

Principal Investigators

  • Inger Marie Jensen Hansen, Phd, DMSci · Department of Rheumatology, Odense University Hospital, Svendborg Hospital, Svendborg, Denmark.

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-31
Primary Completion
2018-02-28
Completion
2020-02-29

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02985424 on ClinicalTrials.gov